Verition Fund Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $672K | Buy |
41,970
+320
| +0.8% | +$5.12K | ﹤0.01% | 2085 |
|
2025
Q1 | $809K | Sell |
41,650
-44,793
| -52% | -$870K | ﹤0.01% | 1731 |
|
2024
Q4 | $1.9M | Sell |
86,443
-23,816
| -22% | -$525K | 0.01% | 1185 |
|
2024
Q3 | $1.86M | Buy |
110,259
+18,859
| +21% | +$318K | 0.01% | 1028 |
|
2024
Q2 | $1.09M | Buy |
91,400
+8,137
| +10% | +$97.2K | 0.01% | 1116 |
|
2024
Q1 | $923K | Buy |
83,263
+43,369
| +109% | +$481K | 0.01% | 1185 |
|
2023
Q4 | $345K | Sell |
39,894
-2,409
| -6% | -$20.9K | ﹤0.01% | 1321 |
|
2023
Q3 | $324K | Buy |
42,303
+32,045
| +312% | +$245K | ﹤0.01% | 1384 |
|
2023
Q2 | $73.9K | Buy |
+10,258
| New | +$73.9K | ﹤0.01% | 1728 |
|